According to Vertex Pharmaceuticals's latest financial reports the company's current EPS (TTM) is $13.09. In 2022 the company made an earnings per share (EPS) of $12.98 an increase over its 2021 EPS that were of $9.10.
Year | EPS | Change |
---|---|---|
2023 (TTM) | $13.09 | 0.85% |
2022 | $12.98 | 42.64% |
2021 | $9.10 | -12.67% |
2020 | $10.42 | 128.01% |
2019 | $4.57 | -44.54% |
2018 | $8.24 | 670.09% |
2017 | $1.07 | -327.66% |
2016 | -$0.47 | -79.65% |
2015 | -$2.31 | -26.43% |
2014 | -$3.14 | 53.92% |
2013 | -$2.04 | 316.33% |
2012 | -$0.49 | -545.45% |
2011 | $0.11 | -102.92% |
2010 | -$3.77 | 1.34% |
2009 | -$3.72 | 13.41% |
2008 | -$3.28 | 8.61% |
2007 | -$3.02 | 64.13% |
2006 | -$1.84 | -18.22% |
2005 | -$2.25 | 6.13% |
2004 | -$2.12 | -16.86% |
2003 | -$2.55 | 78.32% |
2002 | -$1.43 | 164.81% |
2001 | -$0.54 |
Company | EPS | EPS differencediff. | Country |
---|---|---|---|
Johnson & Johnson JNJ | $14.09 | 7.60% | ๐บ๐ธ USA |
AbbVie ABBV | $3.68 | -71.88% | ๐บ๐ธ USA |
Gilead Sciences GILD | $4.39 | -66.46% | ๐บ๐ธ USA |
Merck MRK | $1.82 | -86.08% | ๐บ๐ธ USA |
Bristol-Myers Squibb BMY | $3.97 | -69.67% | ๐บ๐ธ USA |
Enanta Pharmaceuticals
ENTA | -$6.31 | -148.20% | ๐บ๐ธ USA |